Crescita Therapeutics
(OTC) CRRTF
This security has been delisted. This page is retained for historical reference.
CRRTF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowCRRTF Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
-5%
Net Income Margin
-1%
Return on Equity
-2%
Return on Capital
-7%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
CA$10.36M
Operating Income
-CA$1.02M
EBITDA
CA$478.61K
Operating Cash Flow
CA$1.07M
Capital Expenditure
-CA$332.73K
Free Cash Flow
CA$739.40K
Cash & ST Invst.
CA$8.57M
Total Debt
CA$333.73K
Crescita Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$5.65M
+59.8%
Gross Profit
CA$2.46M
+40.5%
Gross Margin
43.45%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
71
N/A
Net Income
-CA$1.16M
-24.8%
EBITDA
-CA$820.11K
-44.6%
Quarterly Fundamentals
Total Cash
CA$8.73M
+2.3%
Total Debt
CA$2.51M
+249.2%
Accounts Receivable
CA$2.56M
+63.2%
Inventory
CA$4.18M
-17.9%
Long Term Debt
CA$2.09M
+758.4%
Short Term Debt
CA$413.06K
-12.9%
Return on Assets
-1.44%
N/A
Return on Invested Capital
-7.04%
N/A
Free Cash Flow
CA$124.32K
+121.5%
Operating Cash Flow
CA$142.37K
+127.8%